Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$132K Buy
333
+91
+38% +$25.9K ﹤0.01% 868
2026
Q1
$42K Buy
+242
New +$49.6K ﹤0.01% 1096
2025
Q4
– Sell
-132
Closed -$34.3K – 1090
2025
Q3
$34.3K Buy
+132
New +$34.7K ﹤0.01% 994
2025
Q2
– Sell
-175
Closed -$46.3K – 1105
2025
Q1
$46.3K Sell
175
-61
-26% -$16.5K ﹤0.01% 907
2024
Q4
$59.7K Buy
236
+41
+21% +$11K ﹤0.01% 833
2024
Q3
$61.8K Sell
195
-156
-44% -$55.5K ﹤0.01% 837
2024
Q2
$122K Sell
351
-88
-20% -$29.7K ﹤0.01% 758
2024
Q1
$201K Buy
+439
New +$166K ﹤0.01% 526
2023
Q3
– Sell
-57
Closed -$25.5K – 573
2023
Q2
$25.5K Buy
+57
New +$28.7K ﹤0.01% 578

Other funds holding HUM

Mather Group's HUM Position: Q2 2026 in Review

Mather Group increased its Humana (HUM) stake by 38% in Q2 2026, buying an estimated $25.9K and bringing the position to 333 shares worth $132K. The position accounts for ﹤0.01% of the portfolio, ranked #868.

Mather Group first reported a position in HUM in Q2 2023 and has held it in 9 quarters since. The position peaked at $201K in Q1 2024. 928 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • Mather Group held 333 shares of Humana worth $132K as of Q2 2026.
  • Mather Group bought 91 Humana shares in Q2 2026, an estimated $25.9K.
  • Humana made up ﹤0.01% of Mather Group's portfolio in Q2 2026, its #868 holding.
  • Mather Group first reported a position in Humana in Q2 2023 and has held it in 9 quarters since.
  • Mather Group's Humana position peaked at $201K in Q1 2024.
  • 928 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on Mather Group's 13F filing for Q2 2026, filed 27 Jul 2026.